Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 54,100
-1,500 (-2.70%)
Aug 7, 2026, 3:30 PM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.75 trillion as of August 7, 2026. Its market cap has increased by 95.51% in one year.
Market Cap
2.75T
Enterprise Value
2.76T
Revenue
159.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
54,100.00
ChartMarket Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.75T, an increase of 10,348.40%. That is a compound annual growth rate of 16.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.75T | 23.69% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.01T |
| Hanmi Pharm. | 4.98T |
| Celltrion Pharm | 1.95T |
| Daewoong Pharmaceutical | 1.48T |
| GC Biopharma | 1.48T |
| Chong Kun Dang Pharmaceutical | 928.91B |
| DongKook Pharmaceutical | 870.64B |
| Daewoong | 754.14B |